Results of a Preliminary Study of Consumer Attitudes on Hypertension Screening by Pharmacists

U.S. Department of Health, Education, and Welfare, National Institutes of Health, Public Health Service, Executive Summary of the Task Force Reports to the Hypertension Information and Education Advisory Committee, DHEW Publication No. (NIH) 74–592, (173), National Institutes of Health, Bethesda, Md. 2014, pp. 9–10.

Heil George C. Stewart Ronald L. : Key Role Awaits Community Pharmacists in High Blood Pressure Education Program, Pharm. News 14 (2): 1–3 (Fall) 1973.

Stokes John B. III : The National High Blood Pressure Education Program, J. Am. Pharm. Assoc. NS14: (4) 172–176 (Apr.) 1974.

McKenney James M. : Pharmacy Management of Hypertensive Patients, J. Am. Pharm. Assoc. NS14: (4) 190–195 (Apr.) 1974.

McKenny James M. Slining Judith M. Hendelson H. Richard Devins Douglas Barr Martin : The Effect of Clinical Pharmacy Services on Patients with Essential Hypertension, Circulation 48: 1104–1111 (Nov.) 1973.

Hammel Maxine I. Kabat Hugh F. : A Case Study: Blood Pressure Screening in the Community Pharmacy, J. Am. Pharm. Assoc. NS14: (4) 196–197 (Apr.) 1974.

Skhal John T. : California Pharmaceutical Association's Hypertensive Program, J. Am. Pharm. Assoc. NS14: (4) 198 (Apr.) 1974.

Hypertension : Silent Killer, Am. Druggist 169 (12): 45 (June 15) 1974.

Griffenhagen George B. : Let's Diffuse This Time Bomb, J. Am. Pharm. Assoc. NS14: (4) 171 (Apr.) 1974.

Thwaites Keith J. : The American Heart Association Views the Pharmacist as a Community Resource, J. Am. Pharm. Assoc. NS14: (4) 177–185 (Apr.) 1974.

Reutershan Thomas A. : CTHBP Views the Need for a Citizens' Organization, J. Am. Pharm. Assoc. NS14: (4) 178–189 (Apr.) 1974.

Mattei Thomas J. Balmer James A. Duffy Sister Gonzales M. : A Hypertensive Patient Needs, J. Am. Pharm Assoc. NS14 (4): 186–189 (Apr.) 1974.

Zaludek Gloria : New Role for the Pharmacist in Hypertension, Am. Drug. 169 (12): 43–44 (June 15) 1974.

Williams Ronald L. : Should the Pharmacist Take the Patient's Blood Pressure?, J. Am. Pharm. Assoc. NS14: (4) 203 (Apr.) 1974.

Gagnon J. P. : Breakdown of the Importance and Cost of Pharmaceutical Services by Consumer Demographic Characteristics. Paper presented before the Section on Economics and Administrative Sciences of the Academy of Pharmaceutical Sciences at the annual meeting of the American Pharmaceutical Association, April 22, 1975, San Francisco, California.

Kotzan J. A. Braucher C. L. : A Multivariate Analysis of Retail Prescription Prices, J. Marketing Res. 7: 518 (Nov.) 1970.

Gagnon J. P. : Pharmaceutical Services — Consumer Perceptions, J. Am. Pharm. Assoc. NS16: 137 (Mar.) 1976.

Anon.: The Hypertension Handbook, Merck, Sharp & Dohme, Division of Merck & Company, Inc., West Point, Pa. 1986, 1974, p. 4.

Wall Jerry L. : What the Competition is Doing — Your Need to Know, Harvard Business Rev. 52 (6): 10–11 (Nov.-Dec.) 1974.

Executive Summary of the Task Force Reports to the Hypertension Information and Education Advisory Committee, National Institutes of Health, Public Health Service, U.S. Department of Health, Education, and Welfare, pp. 9–10.